SPDL1 and familial pancreatic carcinoma: In this study, pancreatic cancer patients with high sPD-L1 levels at the time of diagnosis showed significantly worse OS than patients with low sPD-L1 levels despite identical FOLFIRINOX chemotherapy treatment.